medicineBusinessMark Cuban’s War on Drug Prices: ‘How Much Fucking Money Do I Need?’By Marah EakinScienceThese Stem Cell Treatments Are Worth Millions. Donors Get Paid $200By Matt ReynoldsScienceWhy an Offline Nuclear Reactor Led to Thousands of Hospital Appointments Being CanceledBy Chris BaraniukScienceNeuralink Plans to Test Whether Its Brain Implant Can Control a Robotic ArmBy Emily MullinScienceWhy Is There So Much Off-Brand Oral Ozempic for Sale Online?By Kate Knibbs and Emily MullinGearWhy Snail Mucin? Or, How This Ancient Practice Became a Skin Care SensationBy Boutayna Chokrane ScienceThe First Crispr Treatment Is Making Its Way to PatientsBy Emily MullinScienceBone Marrow Donors Can Be Hard to Find. One Company Is Turning to CadaversBy Emily MullinScienceA Popular Decongestant Doesn’t Work. The FDA Is Finally Doing Something About ItBy Beth Mole, Ars TechnicaPoliticsDonald Trump Vows to Let Robert F. Kennedy Jr. ‘Go Wild on Health’ If ElectedBy Vittoria ElliottScienceA Neuralink Rival Says Its Eye Implant Restored Vision in Blind PeopleBy Emily MullinScienceThe Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster DrugBy Kate Knibbs and Emily MullinScienceHow to Close the Gender Health GapBy Anna ByrneScienceThe Crackdown on Compounded GLP-1 Meds Has BegunBy Kate KnibbsScienceA Major GLP-1 Drug Shortage Is Over. Some Patients Aren’t CelebratingBy Kate KnibbsScienceThe Gut Might Hold the Key to Treating Long Covid in KidsBy David CoxScienceRSV Can Be a Killer. New Tools Are Identifying the Most At-Risk KidsBy David CoxScienceScientists Crack a 50-Year Mystery to Discover a New Set of Blood GroupsBy Chris BaraniukScienceThe Uncertain Path Forward for Psychedelic MedicineBy Emily MullinScienceThis Code Breaker Is Using AI to Decode the Heart’s Secret RhythmsBy Amit KatwalaScienceHow Do You Get Drugs to the Brain? Maybe Try a ParasiteBy Bill SullivanScienceThe Benefits of Ozempic Are MultiplyingBy Emily MullinScienceThe Race for the Next OzempicBy Emily MullinScienceHospitals Around the World Are Struggling in the Aftermath of the Great IT MeltdownBy David CoxMore Stories
